======= CHST13 ======= == Gene Information == * **Official Symbol**: CHST13 * **Official Name**: carbohydrate sulfotransferase 13 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=166012|166012]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NET6|Q8NET6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHST13&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHST13|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610124|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene belongs to the sulfotransferase 2 family. It is localized to the golgi membrane, and catalyzes the transfer of sulfate to the C4 hydroxyl of beta-1,4-linked N-acetylgalactosamine (GalNAc) flanked by glucuronic acid residue in chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. [provided by RefSeq, Aug 2011]. * **UniProt Summary**: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Transfers sulfate to the C4 hydroxyl of beta1,4-linked GalNAc that is substituted with a beta-linked glucuronic acid at the C-3 hydroxyl. No activity toward dermatan. |Sulfotransfer 2| |chondroitin 4-sulfotransferase activity| |N-acetylgalactosamine 4-O-sulfotransferase activity| |chondroitin sulfate biosynthetic process| |chondroitin sulfate proteoglycan biosynthetic process| |sulfotransferase activity| |chondroitin sulfate metabolic process| |chondroitin sulfate proteoglycan metabolic process| |proteoglycan biosynthetic process| |proteoglycan metabolic process| |glycosaminoglycan biosynthetic process| |mucopolysaccharide metabolic process| |aminoglycan biosynthetic process| |carbohydrate biosynthetic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |sulfur compound biosynthetic process| |glycoprotein biosynthetic process| |sulfur compound metabolic process| |glycoprotein metabolic process| |carbohydrate metabolic process| |Golgi membrane| |carbohydrate derivative biosynthetic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp135|MS023 7μM R03 exp135]]|-1.94| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13492 * **Expression level (log2 read counts)**: -2.6 {{:chemogenomics:nalm6 dist.png?nolink |}}